Question 1

What is EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE used for?

Accepted Answer

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (brand name Emtricitabine and tenofovir disoproxil fumarate) is a Other indicated for 1 INDICATIONS AND USAGE HIV-1 Treatment ( 1.1 ) Emtricitabine and tenofovir disoproxil fumarate tablet is a two-drug combination of emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, Warnings and Precautions ( 5.2 )]..

Question 2

How does EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE work?

Accepted Answer

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE works through the following mechanism: 12.1 Mechanism of Action Emtricitabine and tenofovir disoproxil fumarate is a fixed-dose combination of antiviral drugs FTC and TDF [see Microbiology ( 12.4 )] ..

Question 3

What are the most common side effects of EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE the same as Emtricitabine and tenofovir disoproxil fumarate?

Accepted Answer

Emtricitabine and tenofovir disoproxil fumarate is a brand name for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations